Analysts Are Bullish on These Healthcare Stocks: Sanofi (SNYNF), Healthequity (HQY)
Wells Fargo Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $125
KeyBanc Maintains HealthEquity(HQY.US) With Buy Rating, Cuts Target Price to $100
Keybanc Maintains Overweight on HealthEquity, Lowers Price Target to $100
Barrington Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $112
Analysts' Top Healthcare Picks: Healthequity (HQY), Cingulate Inc (CING)
HealthEquity Price Target Maintained With a $112.00/Share by Barrington Research
HealthEquity Is Maintained at Outperform by Barrington Research
J.P. Morgan Maintains HealthEquity(HQY.US) With Buy Rating, Announces Target Price $100
Goldman Sachs Keeps Their Hold Rating on Healthequity (HQY)
HealthEquity Analyst Ratings
Raymond James Maintains HealthEquity(HQY.US) With Buy Rating, Cuts Target Price to $115
Raymond James Upgrades HealthEquity to Strong Buy, Lowers Price Target to $115
HealthEquity Is Maintained at Overweight by Keybanc
HealthEquity Analyst Ratings
KeyBanc Maintains HealthEquity(HQY.US) With Buy Rating, Raises Target Price to $110
Wells Fargo Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $125
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY) and Alnylam Pharma (ALNY)
A Quick Look at Today's Ratings for HealthEquity(HQY.US), With a Forecast Between $110 to $130
Buy Rating Affirmed for Healthequity Amid Strong Revenue Outlook and Growth Potential